Epstein‐Barr virus related gastric cancer in Japan: A molecular patho‐epidemiological study

Epstein‐Barr virus (EBV) involvement in gastric carcinoma has been demonstrated by the presence of EBV genomes and EBV‐encoded small RNA (EBER) in the carcinoma cells, monoclonal proliferation of EBV‐infected carcinoma cells and elevated antibody titers. The present study was conducted to investigate the prevalence of EBV involvement among gastric carcinomas observed in nine Japanese cities with varying gastric cancer rates. In situ hybridization of EBER‐1 was applied to paraffin sections from 1848 carcinomas observed in 1795 cases and EBV involvement was detected based on uniform hybridization in carcinoma cells. Epstein‐Barr virus was detected in 6.6% of lesions and 6.7% of cases. The rate of EBV involvement did not vary significantly for each city and there was no correlation with underlying gastric cancer mortality rates. Thus, geographic variation of gastric cancer rates within Japan cannot be explained in terms of EBV involvement. Epstein‐Barr virus‐related gastric carcinoma is one of the most common EBV‐related tumors in Japan. The involvement of EBV was significantly more frequent among males than among females, mainly for cancers occurring in the upper and middle part of the stomach, and exhibited more variation by cell type among males. These observations suggest that other factors yet to be discovered may modulate the causal role of EBV in gastric carcinogenesis.